To pathologize is to treat something as a medical or psychological disorder when it might otherwise be understood as a normal variation of human experience. The concept sits at the center of ongoing fights in medicine, psychiatry, and culture about where the boundary falls between “healthy but different” and “sick.” That boundary has shifted dramatically over the past half-century, sometimes in directions that helped people and sometimes in directions that harmed them, and the forces pushing it are not always the ones you would expect.
Where the Line Between Normal and Disordered Falls
The question of what counts as a genuine disorder, rather than a difference that society finds inconvenient or unfamiliar, is not just a philosophical puzzle. It determines who gets treatment, who gets insurance coverage, who gets accommodated at school or work, and who gets stigmatized. Two of the most influential frameworks in the philosophy of medicine disagree on exactly where the line belongs.
One view holds that a disorder exists whenever a biological mechanism fails to do what it evolved to do. Under this framework, the line is drawn by biology alone: if something in your body or brain is not functioning as nature designed it, you have a disorder, regardless of whether it bothers you or anyone else. The competing view adds a second requirement: the malfunction also has to cause harm to the person experiencing it. Without harm, there is no disorder, just a quirk of biology.1The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine. The Biostatistical Theory Versus the Harmful Dysfunction Analysis, Part 1: Is Part-Dysfunction a Sufficient Condition for Medical Disorder?
The difference matters more than it sounds. Under the biology-only model, you can be “disordered” without suffering, which opens the door to pathologizing traits that are statistically unusual but perfectly livable. Under the harm-required model, the door is narrower, but who decides what counts as harm? A person who is deeply introverted in a society that prizes extroversion may experience real professional and social consequences. Does that make introversion harmful, or does it make the society poorly designed? These frameworks do not settle the argument so much as clarify what people are actually arguing about when they accuse someone of pathologizing normal behavior.
Diagnostic Expansion in Psychiatry
Psychiatric diagnosis has not stayed still. Each revision of the major diagnostic manuals has tweaked the criteria for who qualifies for a given label, and the tweaks have not been random. A meta-analysis tracking changes from the third edition of the DSM through the fifth found that several major categories experienced what researchers call “diagnostic inflation,” meaning the criteria became less strict over time, pulling more people into the diagnostic net. ADHD, autism, eating disorders, and substance dependence all showed reliable evidence of loosened thresholds.2PubMed. Diagnostic inflation in the DSM: A meta-analysis of changes in the stringency of psychiatric diagnosis from DSM-III to DSM-5
Some of that loosening corrected genuine problems. Earlier editions of the DSM missed people who were clearly struggling because the criteria were too narrow or too culturally specific. But the pattern also raises an uncomfortable question: if every revision tends to widen the circle of who counts as disordered, is the field converging on the truth, or is it drifting toward a world where more and more ordinary variation gets a clinical label? The answer is probably both, and the proportion varies by disorder.
Grief as a Test Case
No single change to a diagnostic manual sparked as much public debate as the removal of the bereavement exclusion in DSM-5. For decades, the manual had included a carve-out: if you met the criteria for major depression but your symptoms had started within two months of losing a loved one, you were excluded from the diagnosis. The reasoning was that intense sadness, poor sleep, and loss of appetite after a death are normal parts of grief, not mental illness.
DSM-5 dropped that exclusion. Supporters argued there was no scientific basis for treating bereavement-triggered depression differently from depression triggered by a job loss, a divorce, or anything else. If someone meets the criteria and is suffering, the argument went, withholding a diagnosis just because the cause was bereavement denies them access to treatment.3PubMed Central. The Bereavement Exclusion and DSM-5: An Update and Commentary
Critics pushed back hard. A detailed review of the evidence cited in favor of removing the exclusion found that much of it did not actually test what it claimed. Several studies that supposedly showed bereavement-related depression was identical to other depression had sampled people who would not have been excluded under the old rule anyway, making their findings irrelevant to the question at hand. Meanwhile, more recent studies comparing people who would have been excluded with those who had standard major depression found meaningful differences in recurrence rates, supporting the idea that the exclusion was catching something real.4World Psychiatry. Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5?
The grief debate is a clean example of what pathologizing looks like in practice. Nobody disputes that some grieving people develop clinical depression that warrants treatment. The argument is about whether the diagnostic system should include a safeguard against labeling normal grief as illness, or whether any such safeguard inevitably blocks some genuinely ill people from getting help. Both sides have a point, which is exactly what makes pathologization debates so difficult to resolve.
Sexuality and Gender Identity
The most dramatic example of depathologization in modern psychiatry is the removal of homosexuality from the DSM. In 1973, the American Psychiatric Association voted to drop the diagnosis after decades of competing theories, some treating homosexuality as a pathology and others viewing it as a normal variation of human sexuality.5PubMed Central. Out of DSM: Depathologizing Homosexuality The decision did not happen because new brain scans or genetic studies settled the question. It happened because the framework that had treated homosexuality as disordered was recognized as reflecting cultural prejudice more than clinical evidence. The science had not changed much; the society evaluating it had.
Gender identity has followed a slower, more complicated arc. The World Health Organization’s ICD-11 moved gender incongruence out of the mental disorders chapter entirely and placed it in a new chapter on sexual health. Under ICD-11, gender incongruence is explicitly not a mental disorder, and neither distress nor impaired functioning is required for the category to apply.6PubMed Central. Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations The American Psychiatric Association’s DSM-5, by contrast, still uses the term “gender dysphoria” and keeps it within the mental disorders classification, though with the stated intent of reducing stigma compared to the older term “gender identity disorder.”7PubMed Central. Validity of Categories Related to Gender Identity in ICD-11 and DSM-5 Among Transgender Individuals who Seek Gender-Affirming Medical Procedures
The tension here is practical as much as philosophical. Many transgender people need access to medical services like hormone therapy or surgery, and in most healthcare systems, access requires a diagnosis. Removing the category entirely could mean losing insurance coverage. Keeping it risks branding a normal aspect of human identity as a psychiatric condition. The ICD-11 approach of retaining a diagnostic home while moving it out of the mental disorders chapter represents one attempt to thread that needle.
Who Pushes the Boundaries
If you assume that pathologization is driven mainly by doctors expanding their professional territory, you are working with an outdated model. Research into the “engines of medicalization” over recent decades has found that the drivers have shifted. The pharmaceutical industry, consumer advocacy groups, and the economics of managed care now play larger roles than physician groups in deciding what gets classified as a medical problem. Doctors remain the gatekeepers for treatment, but their influence over which conditions get defined as treatable in the first place has become more subordinate.8PubMed. The shifting engines of medicalization
The pharmaceutical industry’s role is especially well documented. Drug companies have been described as actively sponsoring disease-awareness campaigns designed to persuade healthy people that they are sick, convince people with mild problems that their condition is serious, and reframe ordinary experiences like shyness as psychiatric disorders such as social anxiety.9PubMed Central. Disease mongering and drug marketing. Does the pharmaceutical industry manufacture diseases as well as drugs? This is not a conspiracy theory; it is a documented marketing strategy. When a condition lacks a treatment, there is no financial incentive to define it. When a treatment exists, defining the condition broadly means more prescriptions.
Consumer demand also matters. Patient advocacy groups have sometimes pushed for conditions to be recognized as medical disorders specifically so that sufferers can access insurance coverage, workplace accommodations, and public sympathy. The relationship between advocates and industry is not always adversarial. Both can benefit from broader definitions, even when their motivations differ.
When Immaturity Looks Like a Disorder
One of the clearest illustrations of pathologizing normal variation comes from the “relative age effect” in ADHD diagnosis. Children who are the youngest in their class, born just before the school entry cutoff date, are significantly more likely to be diagnosed with ADHD and prescribed medication for it. A large meta-analysis covering over eight million children found that the relatively youngest students had about a 34 percent higher risk of receiving an ADHD diagnosis compared to the oldest students in the same grade.10PubMed. Relative Age and Attention-Deficit/Hyperactivity Disorder: Data From Three Epidemiological Cohorts and a Meta-analysis
A more recent systematic review confirmed the pattern, finding a relative risk of about 1.38 for ADHD diagnosis among the youngest children in a class and about 1.28 for ADHD medication prescriptions. The review also suggested that differences in teacher and parent ratings of behavior contribute to the effect, meaning the adults evaluating these children are interpreting age-appropriate immaturity as symptoms of a disorder.11PubMed Central. Systematic review and meta-analysis: relative age in attention-deficit/ hyperactivity disorder and autism spectrum disorder
This does not mean ADHD is not real. It means the diagnostic process is sensitive enough to context that a child who is simply eleven months younger than their classmates faces a meaningfully higher chance of being labeled disordered and medicated. The youngest child in a class of five-year-olds may be nearly 20 percent younger in developmental terms than the oldest. That gap in maturity is not a brain malfunction. It is arithmetic.
Race and Diagnostic Patterns
Pathologization does not fall evenly across populations. Analysis of a large U.S. national inpatient sample found that among pediatric patients already diagnosed with ADHD or a disruptive behavior disorder, race was correlated with the specific diagnosis received. Native American, Asian, Black, and Hispanic children were all more likely than white children to receive a disruptive behavior disorder diagnosis (as opposed to an ADHD diagnosis), with Native American children facing more than double the odds.12PubMed Central. Racial disparities in the diagnosis of disruptive behavior disorders: a U.S. national inpatient sample analysis
The picture is complicated, though. At least one study using controlled experimental methods, presenting physicians with identical clinical scenarios but varying the child’s race, found no significant differences in how physicians diagnosed or treated the case.13PubMed. Does Patient Race/Ethnicity Influence Physician Decision-Making for Diagnosis and Treatment of Childhood Disruptive Behavior Problems? That gap between real-world diagnostic patterns and controlled experiments suggests that racial disparities in diagnosis may arise less from individual physician bias in a single encounter and more from systemic factors: who gets referred in the first place, what information accompanies the referral, how families interact with the healthcare system, and which behaviors get flagged by schools. The pathologization of behavior is not race-neutral, but the mechanisms producing the disparity are more diffuse than a single prejudiced clinician.
Social Media and the Rise of Self-Pathologizing
A newer dimension of pathologization bypasses clinicians entirely. Mental health content has exploded on social media platforms, and research is beginning to document its effects on how young people understand their own experiences. A pilot study of youth entering treatment for mood and anxiety disorders found that all participants had viewed mental health content online, with social media sites viewed more frequently than academically oriented sources. Most of the patients reported believing they had diagnoses that no clinician had ever given them, and most said social media contributed to that belief. The frequency of viewing mental health content on platforms like YouTube was correlated with self-diagnosis.14PubMed. Self-diagnosis in the age of social media: A pilot study of youth entering mental health treatment for mood and anxiety disorders
Researchers have flagged the clinical implications of this pattern, calling for tools to identify and address what they describe as harmful self-pathologizing of normal behavioral variants in young adults.15Discover Psychology. Inside the black mirror: current perspectives on the role of social media in mental illness self-diagnosis The concern is not that people should avoid learning about mental health. It is that short-form content designed for engagement tends to present disorder criteria in stripped-down, relatable ways that make almost anyone feel like they qualify. A video listing ADHD symptoms as “trouble focusing,” “losing your keys,” and “getting bored easily” describes the average Tuesday for most people. When those descriptions circulate without context, normal experiences start to feel clinical.
What Happens When You Get the Label
Being pathologized is not just an abstract categorization. Research informed by modified labeling theory has explored how receiving a psychiatric diagnosis changes the way people see themselves. Once someone is labeled, cultural ideas about mental illness become personally relevant to them, which can foster negative self-feelings. The severity of this effect depends on the specific diagnosis: different diagnostic categories moderate how strongly stigma sentiments shape a person’s sense of self and their perception of how others view them.16Social Psychology Quarterly. Exploring the Role of Diagnosis in the Modified Labeling Theory of Mental Illness
At the same time, labels are not purely harmful. An analysis of the role diagnostic labels play across scientific, therapeutic, social, and administrative contexts found that labels serve different purposes in each setting and benefit different groups of people.17PubMed Central. Who benefits from diagnostic labels for developmental disorders? In the administrative context, a diagnosis can unlock funding, accommodations, and legal protections. In the therapeutic context, it can guide treatment selection. In the social context, it can provide a community and a shared language for describing struggles. And in the scientific context, it allows researchers to study a group and develop interventions. The question “should we pathologize this?” rarely has a clean answer, because the benefits and costs of the label land on different people in different proportions.
The Cultural Lens
Psychiatric diagnosis does not exist outside culture. What gets classified as a disorder reflects the social and political context of the era. For decades, conditions reported mainly in non-Western societies, sometimes called culture-bound syndromes, were treated as curiosities at the margins of a universal diagnostic system. But scholars have argued that the global dominance of the DSM framework, combined with pharmaceutical market pressures and international health burden studies, has effectively made those syndromes “disappear” by absorbing them into Western categories. Depression, once widely believed to be rare outside the developed West, has rapidly become the dominant narrative of mental distress worldwide.18Psychopathology. Socio-Cultural and Global Health Perspectives for the Development of Future Psychiatric Diagnostic Systems
That shift raises a genuine question about whether global populations genuinely have more depression than previously recognized, or whether a Western diagnostic framework is being exported in a way that reinterprets local experiences of distress through a lens of pathology. The answer is probably some of both, but the near-total dominance of one diagnostic tradition makes it hard to evaluate the question fairly.
An Evolutionary Wrinkle
Evolutionary psychology adds another layer to the pathologization debate. Some conditions currently classified as disorders, because they cause distress and impair functioning, may actually be produced by biological adaptations operating exactly as natural selection designed them to operate.19PubMed Central. Using Evolutionary Theory to Guide Mental Health Research Anxiety in the face of genuine threat, low mood after a serious social loss, hypervigilance in an unpredictable environment: these responses are unpleasant, but they may be functional. They become disorders under current frameworks mainly because they are distressing, not because the underlying mechanisms are broken.
This perspective does not mean you should ignore your anxiety because it is “natural.” It means the framework that defines disorder by distress alone risks confusing an alarm system that is working correctly with one that is malfunctioning. A smoke detector that goes off when there is a fire is not broken. A smoke detector that goes off every time you make toast may not be broken either, exactly; it is just responding to a threshold that does not match your environment. Deciding whether to recalibrate the detector (treat the condition) or redesign the kitchen (change the environment) depends on which framing you adopt.
Violence and the Comfort of a Diagnosis
Pathologization extends beyond medicine into how society processes events it finds disturbing. After mass violence, there is a strong reflexive push to explain the perpetrator’s actions through mental illness. Analysis of this pattern suggests the rush to pathologize criminal behavior serves several psychological functions for the public: it protects the belief that the world is fundamentally fair, it maintains psychological distance from the human capacity for harm, and it avoids uncomfortable questions about systemic failures.20Journal of the Academy of Forensic Nursing. The Comfort of Madness: How Society’s Need to Pathologize Violence Undermines Justice and Stigmatizes Mental Illness
The cost of this reflex falls on people who actually live with mental illness. Rates of violence among people with psychiatric diagnoses are only modestly elevated compared to the general population, and most violent acts are committed by people without any diagnosable condition. When every mass shooting triggers a discussion about “mental health,” the implicit message is that mental illness and dangerousness are linked, which deepens stigma and discourages people from seeking help. Pathologizing violence to make it comprehensible is understandable as a psychological defense, but it does real damage to an already vulnerable group.
Body Size and the Obesity Question
The debate over whether obesity should be treated as a disease is another active front. In 2013, the American Medical Association voted to classify obesity as a disease, a decision that was controversial even within the organization. Research into how practitioners actually handle obesity in clinical settings has found an uneven picture, with calls for physicians to reflect on their biases in treating obesity as a chronic disease.21PubMed Central. The Incomplete Medicalization of Obesity: Physician Office Visits, Diagnoses, and Treatments, 1996-2014
Critical scholars have argued that the tool most commonly used to define obesity, the body mass index, functions less as a straightforward health measure and more as a product of medicalization and evidence-based medicine’s demand for quantifiable thresholds. BMI collapses a complex relationship between body composition and health into a single number, and the cutoff points that separate “normal” from “overweight” from “obese” are not as biologically grounded as they appear. The measure has been described as “performative,” meaning it does not just reflect reality but actively shapes how bodies are categorized and treated.22PubMed Central. In BMI We Trust: Reframing the Body Mass Index as a Measure of Health None of this means weight has no relationship to health. It means the line between “person with a health risk” and “person with a disease” is drawn partly by medical evidence and partly by social forces that have little to do with biology.